Artículo

Cosolvent Sites-Based Discovery of Mycobacterium Tuberculosis Protein Kinase G Inhibitors

Burastero, Osvaldo Icon; Defelipe, Lucas Alfredo Icon; Gola, Gabriel Francisco Icon; Tateosian, Nancy Liliana Icon; Lopez, Elias Daniel Icon; Martinena, Camila Belen ; Arcon, Juan Pablo Icon; Dodes Traian, Martín Miguel Icon; Wetzler, Diana Elena Icon; Bento, Isabel ; Barril, Xavier ; Ramirez, Javier Alberto Icon; Marti, Marcelo Adrian Icon; Maria, Garcia Alai ; Turjanski, Adria

Otros responsables

Fecha

07/2022

Editorial

American Chemical Society

Revista

Journal of Medicinal Chemistry

Título del libro

Nombre del evento

Fecha del evento

Institución organizadora

ISSN

0022-2623

eISSN

ISBN

Idioma

Inglés

Tipo del evento

Palabras clave

Resumen

Computer-aided drug discovery methods play a major role in the development of therapeutically important small molecules, but their performance needs to be improved. Molecular dynamics simulations in mixed solvents are useful in understanding protein-ligand recognition and improving molecular docking predictions. In this work, we used ethanol as a cosolvent to find relevant interactions for ligands toward protein kinase G, an essential protein of Mycobacterium tuberculosis (Mtb). We validated the hot spots by screening a database of fragment-like compounds and another one of known kinase inhibitors. Next, we performed a pharmacophore-guided docking simulation and found three low micromolar inhibitors, including one with a novel chemical scaffold that we expanded to four derivative compounds. Binding affinities were characterized by intrinsic fluorescence quenching assays, isothermal titration calorimetry, and the analysis of melting curves. The predicted binding mode was confirmed by X-ray crystallography. Finally, the compounds significantly inhibited the viability of Mtb in infected THP-1 macrophages.

Aprobación

Revisión

Complementado por

Referenciado por

Licencia Creative Commons

Excepto donde se indique lo contrario, la licencia de este ítem se describe como by-nc-nd